These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4324836)

  • 21. Platelet aggregation. IV. Platelet phosphodiesterase and its inhibition by vasodilators.
    Vigdahl RL; Mongin J; Marquis NR
    Biochem Biophys Res Commun; 1971 Mar; 42(6):1088-94. PubMed ID: 4323846
    [No Abstract]   [Full Text] [Related]  

  • 22. Assay of cyclic 3',5'-nucleotide phosphodiesterase in tissue homogenates.
    Gulyassy PF; Oken RL
    Proc Soc Exp Biol Med; 1971 May; 137(1):361-5. PubMed ID: 4325779
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of the 3' 5' - cyclic AMP phosphodiesterase inhibitor in potato: feed-back control by inorganic phosphate.
    Shimoyama M; Sakamoto M; Nasu S; Shigehisa S; Ueda I
    Biochem Biophys Res Commun; 1972 Jul; 48(1):235-41. PubMed ID: 4339461
    [No Abstract]   [Full Text] [Related]  

  • 24. Determination of serum tolbutamide and chlorpropamide by high-performance liquid chromatography.
    Hill RE; Crechiolo J
    J Chromatogr; 1978 Jan; 145(1):165-8. PubMed ID: 621243
    [No Abstract]   [Full Text] [Related]  

  • 25. Gas-liquid chromatographic estimation of tolbutamide and chlorpropamide in plasma.
    Prescott LF; Redman DR
    J Pharm Pharmacol; 1972 Sep; 24(9):713-6. PubMed ID: 4404075
    [No Abstract]   [Full Text] [Related]  

  • 26. GLC determination of plasma levels of intact chlorpropamide or tolbutamide.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1976 Apr; 65(4):576-9. PubMed ID: 1271259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release. Properties of islet-cell adenosine 3':5'-cyclic monophosphate phosphodiesterase.
    Sams DJ; Montague W
    Biochem J; 1972 Oct; 129(4):945-52. PubMed ID: 4347900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the mode of action of the sulfonylureas and phenylacetamides in enhancing the effect of vasopressin.
    Lozada ES; Gouaux J; Franki N; Appel GB; Hays RM
    J Clin Endocrinol Metab; 1972 Apr; 34(4):704-12. PubMed ID: 4335106
    [No Abstract]   [Full Text] [Related]  

  • 29. [Structural factors in inhibition of adenosine-3',5'monophosphate-cyclic-phosphodiesterase].
    Lucacchini A; Montali U; Ranieri M; Rossi CA
    Boll Soc Ital Biol Sper; 1972 Jan; 48(1):17-9. PubMed ID: 4338014
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of cyclic adenosine 3':5'-monophosphate in the action of 1,1,1-trichloro-2,2-bis-(p-chlorophenyl)ethane (DDT)on hepatic and renal metabolism.
    Kacew S; Singhal RL
    Biochem J; 1974 Jul; 142(1):145-52. PubMed ID: 4374184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of glibenclamide, chlorpropamide and tolbutamide in plasma by high-performance liquid chromatography with ultraviolet detection.
    Zecca L; Trivulzio S; Pinelli A; Colombo R; Tofanetti O
    J Chromatogr; 1985 Apr; 339(1):203-9. PubMed ID: 3926803
    [No Abstract]   [Full Text] [Related]  

  • 32. Displacement of tolbutamide, glibencalmide and chlorpropamide from serum albumin by anionic drugs.
    Brown KF; Crooks MJ
    Biochem Pharmacol; 1976 May; 25(10):1175-8. PubMed ID: 820348
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determination of the inhibitory activity of some new substituted theophyllines on the specific phosphodiesterase of cyclic nucleotides].
    Mizon J; Skandrani E; Mizon C
    Therapie; 1971; 26(5):911-7. PubMed ID: 4334256
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclic 3';5' adenosine monophosphate-phosphodiesterase and the release of catabolite repression of beta-galactosidase by exogenous cyclic 3';5' adenosine monophosphate in Escherichia coli.
    Aboud M; Burger M
    Biochem Biophys Res Commun; 1971 Apr; 43(1):174-82. PubMed ID: 4325494
    [No Abstract]   [Full Text] [Related]  

  • 35. Stimulated formation of adenosine 3',5'-monophosphate by desipramine in brain slices.
    Kodama T; Matsukado Y; Suzuki T; Tanaka S; Shimizu H
    Biochim Biophys Acta; 1971 Oct; 252(1):165-70. PubMed ID: 4334914
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC; Smith JB
    Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3':5'-cyclic adenosine monophosphate phosphodiesterase: negative cooperativity.
    Russell TR; Thompson WJ; Schneider FW; Appleman MM
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1791-5. PubMed ID: 4340159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in fibroblasts by intracellular concentrations of cyclic adenosine monophosphate (3T3-dibutyryl cyclic AMP-SV40-transformed cells-michaelis constants-L cells-prostaglandin E 1 ).
    D'Armiento M; Johnson GS; Pastan I
    Proc Natl Acad Sci U S A; 1972 Feb; 69(2):459-62. PubMed ID: 4333987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Effect of vasopressin and chlorpropamide.
    Raij K; Perheentupa J; Härkönen M
    Scand J Clin Lab Invest; 1974 Oct; 34(2):177-84. PubMed ID: 4370673
    [No Abstract]   [Full Text] [Related]  

  • 40. Sulfonylureas and the heart.
    Levey GS; Lasseter KC; Palmer RF
    Annu Rev Med; 1974; 25():69-74. PubMed ID: 4363211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.